Drug Antagonism
-
Subject Areas on Research
- A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.
- Are recombinant human bone morphogenetic protein-7 and tobramycin compatible? An experiment in rats.
- BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1.
- Blocking [211At]astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds.
- Central effects of morphine on GI motility in conscious dogs.
- Cholinergic and adrenergic activating agents as antagonists of the EEG effects of hemicholinium-3.
- Cilostazol to overcome high on-treatment platelet reactivity in korean patients treated with clopidogrel and calcium-channel blocker.
- Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence.
- Effects of physostigmine on rat brain acetylcholine, acetylcholinesterase and conditioned pole jumping.
- Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages.
- New azacannabinoids highly active in the central nervous system.
- Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
- Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials.
- Pharmacologic evidence for cholinergic mechanisms in neocortical and limbic activating systems.
- Protective response of the Ah receptor to ANIT-induced biliary epithelial cell toxicity in see-through medaka.
- Simulation of use-dependent uptake of ion channel blocking agents by excitable membranes.